
We present the first prospective test of zzso zzso in diagnosing normal, benign, and zzso human breast zzso Prospective testing of spectral diagnostic zzso allows clinicians to accurately assess the diagnostic information contained in, and any bias of, the zzso zzso In previous work, we developed an accurate, internally validated zzso for breast cancer diagnosis based on analysis of zzso zzso acquired from zzso in zzso tissue zzso We currently evaluate the performance of this zzso zzso on a large ex zzso clinical data set that closely mimics the in zzso zzso zzso data were collected from freshly excised surgical zzso and 129 tissue sites from 21 patients were zzso Prospective application of the zzso to the clinical data set resulted in a sensitivity of zzso a specificity of zzso a positive zzso value of zzso and a negative zzso value of zzso for distinguishing zzso from normal and benign zzso The performance of the zzso in different patient populations is zzso Sources of bias in the in zzso zzso and ex zzso prospective data sets, including disease prevalence and disease spectrum, are examined and zzso methods for comparison zzso 

